Clinical Trial Update: Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of squalamine lactate and carboplatin for recurrent or refractory stage III/IV ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Squalamine lactate (squalamine lactate)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN